Research
Molecular
The study aims to understand the use of semaglutide for treating obesity and its pharmacological mechanism.
The study may provide insights into how semaglutide works, aiding in treatment decisions.
StrongSupportsmedium confidence
esse trabalho objetiva compreender o uso da semaglutida para o tratamento da obesidade.
Why this rating
The aim of the study is clearly stated and is a foundational aspect of the research.
Source
Uso de semaglutina no tratamento da obesidade / Use of semagglutin in the treatment of obesity
Ana Marcela Teodoro Timo et al. · Brazilian Journal of Health Review · 2022
DOI 10.34119/bjhrv5n3-207
otherCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →